Johnson & Johnson on Tuesday said it could no longer provide a forecast for sales of its COVID-19 vaccine, as vaccine hesitancy in low income countries paired with already low demand in higher income nations has led to a glut of supply. Read More
Toronto Sports News Continuously Updated
Leave a Reply